Julia Schueler, DVM

Head of In Vivo Operations, Oncology
Freiburg
Germany

Julia became part of Charles River when the company acquired Oncotest, which specializes in oncology drug discovery, in 2015. She has held various positions at Oncotest since 2002 and completed post-doctoral research at the Max Planck Institute of Immunobiology.